This site is intended for customers outside the United States. | Switch to: United States
Return Home
Indications and Important Safety Information
Visit Abbott Medical Optics
nav_patient nav_physician


Text Size: SM / MD / LG


The FIRST and ONLY wavefront-designed IOL with claims approved by the US FDA for:

  • Reduced spherical aberration(1)
  • Improved functional vision(1)
  • Improved night driving simulator performance(1)
    Meaningful safety benefit for drivers and pedestrians
    – Improved functional vision for other life situations under low-light conditions

Total Ocular Spherical Aberration of TECNIS® IOL Eyes is Not Significantly Different From Zero(1)*

Mean Spherical Aberration Measurements
Mean Spherical Aberration Measurements, 90±15 Days Postoperatively.
Lens A9000: N = 25. Lens with spherical optic: N = 24.

*The data as it appears here follows the OSA standard and has been changed from the original data to reflect a difference in sign (+or-) that exists between the WASCA measurement and the OSA standard.

  • Multiple studies confirm that peak visual performance occurs at age 19, when spherical aberration is zero.(2,3)
  • Clinical data shows that correcting residual spherical aberration to zero results in better visual outcomes and the best depth of focus.(4)

Zero spherical aberration = Peak visual performance


Improved night-driving simulator performance(1)

TECNIS® IOLs are likely to provide a meaningful safety benefit to elderly drivers(1)

Identification distance at 55 mph(1)

Simulated Night-Driving Study
In a simulated night-driving study, the TECNIS® IOL provided an additional 13.716 m of identification distance and a ½ second of reaction time over a spherical IOL.(1)

Indications and Important Safety Information



Federal law restricts this device to sale by or on the order of a physician.


TECNIS® lenses are indicated for the visual correction of aphakia in adult patients in whom a cataractous lens has been removed by extracapsular cataract extraction. These devices are intended to be placed in the capsular bag.


Physicians considering lens implantation under any of the conditions described in the Directions for Use labeling should weigh the potential risk/benefit ratio prior to implanting a lens.


Do not resterilize or autoclave. Use only sterile irrigating solutions such as balanced salt solution or sterile normal saline. Do not store in direct sunlight or over 45°C.

Adverse Events

Adverse events occurred at rates between 1.6% and 3.3% during the clinical trials for TECNIS® IOLs or their “parent” IOLs. These events included macular edema, endophthalmitis, anterior lens tissue ongrowth, lens dislocation, hypopyon, corneal edema, iritis, hyphema, secondary glaucoma, and secondary surgical intervention. 


Reference the Directions for Use for a complete listing of indications, warnings, and precautions.


1. Package Insert. TECNIS® Foldable Posterior Chamber Intraocular Lens. Abbott Medical Optics Inc.
2. Artal P, Alcon E, Villegas E. Spherical aberration in young subjects with high visual acuity. Presented at ESCRS 2006, Paper 558.
3. Holzer MP. Data presented at the19th Congress of German Ophthalmic Surgeons (DOC), Nuremburg, Germany, 2006.
4. Piers PA, Manzanera S, Prieto PM, et al. Use of adaptive optics to determine the optimal ocular spherical aberration. J Cataract Refract Surg. 2007;33:1721-1726.
5. Mester U, Dillinger P, Anterist N. Impact of a modified optic design on visual function: clinical comparative study. J Cataract Refract Surg. 2003;29(4):652-660.
6. Bellucci R, Scialdone A, Buratto L, et al. Visual acuity and contrast sensitivity comparison between TECNIS and AcrySof SA60AT intraocular lenses: a multicenter randomized study. J Cataract Refract Surg. 2005;31(4):712-717.
7. Kennis H, Huygens M, Callebaut F. Comparing the contrast sensitivity of a modified prolate anterior surface IOL and of two spherical IOLs. Bull Soc Belge Ophtalmol. 2004;294:49-58.
8. Packer M, Fine IH, Hoffman RS, Piers PA. Prospective randomized trial of an anterior surface modified prolate intraocular lens. J Refract Surg. 2002;18(6):692-696.
9. Kershner RM. Retinal image contrast and functional visual performance with aspheric, silicone, and acrylic intraocular lenses. Prospective evaluation. J Cataract Refract Surg. 2003;29(9):1684-1694.
10. Martinez Palmer A, Palacin Miranda B, Castilla Cespedes M, et al. [Spherical aberration influence in visual function after cataract surgery: prospective randomized trial.] Arch Soc Esp Oftalmol. 2005;80(2):71-78. Spanish language.

Back to Top of Page

LegalPrivacy PolicyTerms of Use
Visit Abbott Medical Optics Return Home